Daiichinkyo Co (FRA:D4S) FCF Yield % : 5.03 (As of Apr. 30, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Daiichinkyo Co's Trailing 12-Month Free Cash Flow is €3,028 Mil, and Market Cap is €56,703 Mil. Therefore, Daiichinkyo Co's FCF Yield % for today is 5.03%.

The historical rank and industry rank for Daiichinkyo Co's FCF Yield % or its related term are showing as below:

FRA:D4S' s FCF Yield % Range Over the Past 10 Years
Min: -4.25 Med: 2.03 Max: 8.27
Current: 5.03

During the past 13 years, the highest FCF Yield % of Daiichinkyo Co was 8.27%. The lowest was -4.25%. And the median was 2.03%.

FRA:D4S's FCF Yield % is ranked better than
78.95% of 1083 companies
in the Drug Manufacturers industry
Industry Median: -0.61 vs FRA:D4S: 5.03

Daiichinkyo Co's FCF Margin % for the quarter that ended in Mar. 2024 was -4.06%.

Daiichinkyo Co FCF Yield % Historical Data

The historical data trend for Daiichinkyo Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co FCF Yield % Chart

Daiichinkyo Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Yield %

Get a 7-Day Free Trial

2.97

2.05

1.27

0.52

5.12

Daiichinkyo Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															0.69	-3.48	-2.13	33.10	-0.75

Competitive Comparison of Daiichinkyo Co's FCF Yield %

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daiichinkyo Co's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's FCF Yield % falls into.

Daiichinkyo Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Daiichinkyo Co's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	2925.869	/	57122.325
	=	5.12%

Daiichinkyo Co's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-106.905	*	4	/	57122.325
	=	-0.75%

Daiichinkyo Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Daiichinkyo Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Daiichinkyo Co (FRA:D4S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (FRA:D4S) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

DSNKY:USA DSKYF:USA 4568:Japan D4S:Germany

Address

3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426

Website

https://www.daiichisankyo.com

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co (FRA:D4S) Headlines

No Headlines